Hashizume K - Search Results

1

Facial angiofibroma as an initial manifestation in multiple endocrine neoplasia type 1.

Sakurai A, Hashizume K, Fukushima Y. Sakurai A, et al. Among authors: hashizume k. Intern Med. 2008;47(11):1067-8. doi: 10.2169/internalmedicine.47.1127. Epub 2008 Jun 2. Intern Med. 2008. PMID: 18520124 Free article. No abstract available.

2

Multiple endocrine neoplasia type 1 with unusual concomitance of various neoplastic disorders.

Nishimura Y, Yamashita K, Yumita W, Yamazaki M, Katai M, Sakurai A, Hashizume K. Nishimura Y, et al. Among authors: hashizume k. Endocr J. 2004 Feb;51(1):75-81. doi: 10.1507/endocrj.51.75. Endocr J. 2004. PMID: 15004412 Free article.

3

Long-term follow-up of patients with multiple endocrine neoplasia type 1.

Sakurai A, Katai M, Yamashita K, Mori J, Fukushima Y, Hashizume K. Sakurai A, et al. Among authors: hashizume k. Endocr J. 2007 Apr;54(2):295-302. doi: 10.1507/endocrj.k06-147. Epub 2007 Mar 20. Endocr J. 2007. PMID: 17379960 Free article.

4

Pituitary adenomas in adolescent patients with multiple endocrine neoplasia type 1.

Oiwa A, Sakurai A, Sato Y, Sakuma T, Yamashita K, Katai M, Aizawa T, Hashizume K. Oiwa A, et al. Among authors: hashizume k. Endocr J. 2002 Dec;49(6):635-40. doi: 10.1507/endocrj.49.635. Endocr J. 2002. PMID: 12625413 Free article.

5

Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.

Sakurai A, Katai M, Yumita W, Minemura K, Hashizume K. Sakurai A, et al. Among authors: hashizume k. Endocrine. 2004 Feb;23(1):45-9. doi: 10.1385/ENDO:23:1:45. Endocrine. 2004. PMID: 15034196

6

JunD-menin interaction regulates c-Jun-mediated AP-1 transactivation.

Ikeo Y, Yumita W, Sakurai A, Hashizume K. Ikeo Y, et al. Among authors: hashizume k. Endocr J. 2004 Jun;51(3):333-42. doi: 10.1507/endocrj.51.333. Endocr J. 2004. PMID: 15256779 Free article.

7

Novel 14 base-pair deletion of the MEN1 gene in a patient with recurrent primary hyperparathyroidism.

Katai M, Sakurai A, Uchino S, Minemura K, Hashizume K, Fukushima Y. Katai M, et al. Among authors: hashizume k. Jpn J Clin Oncol. 2006 Jun;36(6):395-7. doi: 10.1093/jjco/hyl023. Epub 2006 May 19. Jpn J Clin Oncol. 2006. PMID: 16714299

8

Familial neuroendocrine tumor syndromes: from genetics to clinical practice.

Sakurai A, Katai M, Hashizume K, Fukushima Y. Sakurai A, et al. Among authors: hashizume k. Pituitary. 2006;9(3):231-6. doi: 10.1007/s11102-006-0268-z. Pituitary. 2006. PMID: 17001463 Review.

9

Suppression of insulin-induced AP-1 transactivation by menin accompanies inhibition of c-Fos induction.

Yumita W, Ikeo Y, Yamauchi K, Sakurai A, Hashizume K. Yumita W, et al. Among authors: hashizume k. Int J Cancer. 2003 Mar 1;103(6):738-44. doi: 10.1002/ijc.10885. Int J Cancer. 2003. PMID: 12516092

10

Octreotide as a rapid and effective painkiller for metastatic carcinoid tumor.

Katai M, Sakurai A, Inaba H, Ikeo Y, Yamauchi K, Hashizume K. Katai M, et al. Among authors: hashizume k. Endocr J. 2005 Apr;52(2):277-80. doi: 10.1507/endocrj.52.277. Endocr J. 2005. PMID: 15863961 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

993 results

Search Page

Filters